Search
Now showing items 1-6 of 6
Comparison of glucose tolerance in renal transplant recipients and hemodialysis patients
(2004)
Background: Impaired glucose tolerance is a risk factor for atherosclerosis in hemodialysis patients and renal transplant recipients. Methods: To check the relationship of impaired glucose tolerance with the other ...
Treatment of cyclosporine-induced gingival overgrowth with azithromycin-containing toothpaste
(2006)
Objective: Gingival overgrowth is a complication of cyclosporine therapy following organ transplantation. Oral azithromycin is frequently used to treat this complication. This study examined the efficacy of local azithromycin, ...
Serum Receptor Activator of Nuclear Factor-? B Ligand, Osteoprotegrin, and Intact Parathyroid Hormone in Hemodialysis and Renal Transplant Patients
(2012)
Serum receptor activator of nuclear factor-? B ligand and osteoprotegrin are mediated to vascular calcification in the general population. Our knowledge is very sparse in hemodialysis and renal transplant patients. Receptor ...
Findings of Doppler sonography do not correlate with serum lipoprotein and total homocysteine concentrations in renal transplant recipients
(2005)
Atherosclerosis may be evaluated by structural or functional changes of the main arteries. We sought to investigate the probable associations of static and dynamic arterial changes with lipoprotein (a) and homocysteine ...
Acute phase reactants in hemodialysis and renal transplantation
(2002)
[No abstract available]
Apolipoprotein A polymorphysm predicts lipoprotein A concentration in renal transplant recipients
(2005)
Increased serum lipoprotein(a) is an independent risk factor for atherosclerosis in renal transplant recipients. Higher levels may be due to genetic factors, for example, apolipoprotein A isoforms and/or environmental ...